SCHEMBL4070795

SCHEMBL4070795

OC[C@H]1OC2O[C@@H]2[C@@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4070797 1.00 — —
SCHEMBL18736267 0.92 ALDH1A1 (0.67) —
SCHEMBL4911680 0.92 ALDH1A1 (0.67) —
SCHEMBL28471882 0.92 ALDH1A1 (0.67) —
SCHEMBL890314 0.92 ALDH1A1 (0.67) —
SCHEMBL16016300 0.92 ALDH1A1 (0.67) —
SCHEMBL6266510 0.92 ALDH1A1 (0.67) —
SCHEMBL1193222 0.92 ALDH1A1 (0.67) —
SCHEMBL6450045 0.92 ALDH1A1 (0.67) —
SCHEMBL4911675 0.92 ALDH1A1 (0.67) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1594882-B1 PROCESS FOR PREPARING BRANCHED RIBONUCLEOSIDES FROM 1, 2-ANHYDRORIBOFURANOSE INTERMEDIATES MERCK & CO INC (US) 2009-07-01 — — EP disclosed
US-7339054-B2 Process for preparing branched ribonucleosides from 1,2-anhydroribofuranose intermediates MERCK & CO., INC. (US) 2008-03-04 — — US disclosed
US-7339054-B2 Process for preparing branched ribonucleosides from 1,2-anhydroribofuranose intermediates MERCK & CO., INC. (US) 2008-03-04 — — US disclosed
US-20070037771-A1 Reacting 2-Anhydro-3,5-di-O-(p-toluoyl)-2-C-methyl- alpha -D-ribofuranose with nucleophile such as cytosine, uracil, thymine, hypoxanthine, adenine, guanine, 7-deazaguanine, 7-deazaadenine, 7-deaza-2,6-diaminopurine, and 7-deazahypoxanthine, removing hydroxyl protecting groups MERCK SHARP & DOHME CORP. 2007-02-15 — — US disclosed
US-20070037771-A1 Reacting 2-Anhydro-3,5-di-O-(p-toluoyl)-2-C-methyl- alpha -D-ribofuranose with nucleophile such as cytosine, uracil, thymine, hypoxanthine, adenine, guanine, 7-deazaguanine, 7-deazaadenine, 7-deaza-2,6-diaminopurine, and 7-deazahypoxanthine, removing hydroxyl protecting groups MERCK SHARP & DOHME CORP. 2007-02-15 — — US disclosed
EP-1594882-A1 PROCESS FOR PREPARING BRANCHED RIBONUCLEOSIDES FROM 1, 2-ANHYDRORIBOFURANOSE INTERMEDIATES Merck & Co., Inc. (US) 2005-11-16 — — EP disclosed
WO-2004072090-A1 PROCESS FOR PREPARING BRANCHED RIBONUCLEOSIDES FROM 1, 2-ANHYDRORIBOFURANOSE INTERMEDIATES MERCK & CO. INC. (US) 2004-08-26 — — WO disclosed
Send feedback